Table 1.
Drug-resistant | Drug-responsive | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | First author | Year | Ethnicity | Genotyping methods | GG | GA | AA | G | A | GG | GA | AA | G | A | HWE |
1 | Seo (Japan) | 2008 | Asian | PCR | 102 | 29 | 2 | 233 | 33 | 104 | 35 | 7 | 243 | 49 | 0.087 |
2 | Kim (Korea) | 2009 | Asian | RT-PCR | 162 | 35 | 1 | 359 | 37 | 165 | 27 | 1 | 357 | 29 | 0.926 |
3 | Ufer (Germany) | 2009 | Caucasian | PCR-RFLP | 66 | 48 | 4 | 180 | 56 | 56 | 37 | 10 | 149 | 57 | 0.298 |
4 | Ufer (Germany) | 2011 | Caucasian | PCR | 119 | 48 | 9 | 286 | 66 | 14 | 16 | 2 | 44 | 20 | 0.355 |
5 | Kwan (China) | 2011 | Asian | Mass array | 193 | 65 | 0 | 451 | 65 | 255 | 60 | 4 | 570 | 68 | 0.825 |
6 | Qu (China) | 2012 | Asian | PCR-RFLP | 181 | 35 | 1 | 397 | 37 | 262 | 56 | 2 | 580 | 60 | 0.593 |
PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; HWE, Hardy–Weinberg equilibrium; RT-PCR, reverse transcription PCR.